Sica Gregory T, Ji Hoon, Ros Pablo R
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Clin Liver Dis. 2002 Feb;6(1):165-79, vii. doi: 10.1016/s1089-3261(03)00071-0.
The detection and characterization of liver metastases is well performed with either computed tomography or magnetic resonance imaging. The administration of intravenous contrast is essential for almost all indications, with multiphasic imaging aiding in lesion characterization and detection. The use of multidetected CT (MDCT) provides the ability for optimized vascular and multiplanar imaging, but has also resulted in increased examination complexity. Tissue-specific MR contrast agents can yield the highest rate of lesion detection and thus may be useful in presurgical planning.
